Dr. Lopes is a resercher from Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. She received her bachelorís degree in biomedicine in 2009 from Universidade Federal de CiÍncias da Saķde de Porto Alegre. Dr Lopes received her master's (2012) and PhD (2017) degrees in biochemistry from Universidade Federal do Rio Grande do Sul. During her PhD she spent 1 year at Kingís College London, working in the Institute of Pharmaceutical Science when she obtained a fellowship from CAPES (Brazilian funding agency- Doctorate Sandwich Programme). She also acquired experience in undergraduate and graduate students teaching, presenting in international events and scientific events organization (Free Radicals Course 2008 and Cell Culture Course- 2013).
Dr. Lopes works with Parkinsonís disease since 2008. Her interest in neurodegenerative diseases started during her undergraduation research project, in which she established and standardized retinoic-acid-induced differentiation of SH-SY5Y cells to be used as an in vitro model of Parkinson's disease (Lopes et al, 2010, Brain Research- number of citations: 94). In her masterís degree, she used this model to screen 9 compounds in search for neuroprotective drugs (Lopes et al, 2012, Neurotoxicity Research- number of citations: 15). Lastly, in her PhD, she used differentiated human neuroblastoma SH-SY5Y cells as a cellular model to study the pathophysiological mechanisms of Parkinsonís Disease, focusing on the role of cofilin-1.